# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-037730
Filing Date
2020-08-06
Accepted
2020-08-06 16:10:02
Documents
82
Period of Report
2020-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | dvax-10q_20200630.htm iXBRL | 10-Q | 3153750
2 | EX-10.1 | dvax-ex101_118.htm | EX-10.1 | 226107
3 | EX-10.2 | dvax-ex102_119.htm | EX-10.2 | 15542
4 | EX-10.3 | dvax-ex103_185.htm | EX-10.3 | 285389
5 | EX-31.1 | dvax-ex311_9.htm | EX-31.1 | 17836
6 | EX-31.2 | dvax-ex312_8.htm | EX-31.2 | 17775
7 | EX-32.1 | dvax-ex321_7.htm | EX-32.1 | 6087
8 | EX-32.2 | dvax-ex322_6.htm | EX-32.2 | 6325
| Complete submission text file | 0001564590-20-037730.txt |  | 11665592

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA | dvax-20200630.xsd | EX-101.SCH | 68154
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE | dvax-20200630_cal.xml | EX-101.CAL | 62408
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | dvax-20200630_def.xml | EX-101.DEF | 266538
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | dvax-20200630_lab.xml | EX-101.LAB | 537623
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | dvax-20200630_pre.xml | EX-101.PRE | 419319
14 | EXTRACTED XBRL INSTANCE DOCUMENT | dvax-10q_20200630_htm.xml | XML | 2185827

Mailing Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608
Business Address 2100 POWELL STREET SUITE 900 EMERYVILLE CA 94608 5108485100
DYNAVAX TECHNOLOGIES CORP (Filer) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34207 | Film No.: 201081681
SIC: 2834 Pharmaceutical Preparations